Development of a molecularly imprinted polymer-based electrochemical sensor for the selective detection of nerve agent VX metabolite ethyl methylphosphonic acid in human plasma and urine samples
Analytical and Bioanalytical Chemistry · 2024
DOI: 10.1007/s00216-024-05155-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2024. Verfasst von Sermet Sezigen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical CBRN Defense, University of Health Sciences, Ankara, Türkiye. sermet.sezigen@sbu.edu.tr. Hauptthemen laut MEDLINE: Nerve Agents, Molecular Imprinting, Anthracenes, Organothiophosphorus Compounds. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CRDF Global, University of Health Sciences.
Abstract (Originalsprache)
This study focuses on the detection of ethyl methyl phosphonic acid (EMPA), a metabolite of the banned organophosphorus nerve agent VX. We developed an electrochemical sensor utilizing the molecularly imprinted polymer (MIP) based on 4-aminobenzoic acid (4-ABA) and tetraethyl orthosilicate for the selective detection of EMPA in human plasma and urine samples. The 4-ABA@EMPA/MIP/GCE sensor was constructed by a thermal polymerization process on a glassy carbon electrode and sensor characterization was performed by cyclic voltammetry and electrochemical impedance spectroscopy. The 4-ABA@EMPA/MIP/GCE sensor demonstrated impressive linear ranges 1.0 × 10 –10 M–2.5 × 10 –9 M for the standard solution, 1.0 × 10 –10 M–2.5 × 10 –9 M for the urine sample, and 1.0 × 10 –10 M–1 × 10 –9 M of EMPA for the plasma sample with outstanding detection limits of 2.75 × 10 −11 M (standard solution), 2.11 × 10 −11 M (urine), and 2.36 × 10 −11 M (plasma). The sensor exhibited excellent recovery percentages ranging from 99.86 to 101.30% in urine samples and 100.62 to 101.08% in plasma samples. These findings underscore the effectiveness of the 4-ABA@EMPA/MIP/GCE as a straightforward, highly sensitive, and selective interface capable of detecting the target analyte EMPA in human plasma and urine samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical CBRN Defense, University of Health Sciences, Ankara, Türkiye. sermet.sezigen@sbu.edu.tr.
- Department of Analytical Chemistry, Gulhane Faculty of Pharmacy, University of Health Sciences, Ankara, Türkiye.
- Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Türkiye.
Förderung
- CRDF Global
- University of Health Sciences
Zitieren
APA
Sezigen, S., Kaya, S. I., Bakirhan, N. K., & Ozkan, S. A. (2024). Development of a molecularly imprinted polymer-based electrochemical sensor for the selective detection of nerve agent VX metabolite ethyl methylphosphonic acid in human plasma and urine samples. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-024-05155-6
Vancouver
Sezigen S, Kaya SI, Bakirhan NK, Ozkan SA. Development of a molecularly imprinted polymer-based electrochemical sensor for the selective detection of nerve agent VX metabolite ethyl methylphosphonic acid in human plasma and urine samples. Analytical and Bioanalytical Chemistry. 2024. doi:10.1007/s00216-024-05155-6
BibTeX
@article{Sezigen2024,
author = {Sezigen, Sermet and Kaya, S Irem and Bakirhan, Nurgul K and Ozkan, Sibel A},
title = {Development of a molecularly imprinted polymer-based electrochemical sensor for the selective detection of nerve agent VX metabolite ethyl methylphosphonic acid in human plasma and urine samples},
journal = {Analytical and Bioanalytical Chemistry},
year = {2024},
doi = {10.1007/s00216-024-05155-6}
}
EUVIMED